Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals

Danial E Baker

doi:10.1310/hpj5011-1040

Back

Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals

Journal article

Open access

Peer reviewed

Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals

Danial E Baker

Hospital pharmacy (Philadelphia), Vol.50(11), pp.1040-1050

11/2015

DOI: https://doi.org/10.1310/hpj5011-1040

Handle:

https://hdl.handle.net/2376/107480

PMCID: PMC4750838

PMID: 27621511

Files and links (1)

url

https://doi.org/10.1310/hpj5011-1040View

Published (Version of record) Open

Abstract

Current FDA-Related Drug Information

This monthly feature will help readers keep current on new drugs, new indications, dosage forms, and safety-related changes in labeling or use. Efforts have been made to ensure the accuracy of this information; however, if there are any questions, please let me know at danial.baker@wsu.edu.

Metrics

6 Record Views

Details

Title: Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals
Creators: Danial E Baker - ,
Publication Details: Hospital pharmacy (Philadelphia), Vol.50(11), pp.1040-1050
Academic Unit: Pharmacotherapy, Department of
Publisher: Thomas Land Publishers, Inc
Identifiers: 99900547182401842
Language: English
Resource Type: Journal article